SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-18-008449
Filing Date
2018-06-11
Accepted
2018-06-11 12:29:19
Documents
49

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 1138724
2 ex5-1.htm EX-5.1 11660
3 logo_001.jpg GRAPHIC 7688
4 ex5-1_001.jpg GRAPHIC 18963
  Complete submission text file 0001493152-18-008449.txt   3074423

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ntva-20180331.xml EX-101.INS 270910
6 XBRL SCHEMA FILE ntva-20180331.xsd EX-101.SCH 27866
7 XBRL CALCULATION FILE ntva-20180331_cal.xml EX-101.CAL 31079
8 XBRL DEFINITION FILE ntva-20180331_def.xml EX-101.DEF 156766
9 XBRL LABEL FILE ntva-20180331_lab.xml EX-101.LAB 173406
10 XBRL PRESENTATION FILE ntva-20180331_pre.xml EX-101.PRE 195246
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
Intiva BioPharma Inc. (Filer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-225477 | Film No.: 18891478
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1